Omzo Review

Omzo's sexual-health offer is a compounded 3-in-1 dissolvable troche combining sildenafil, tadalafil, and oxytocin. The first two are PDE5 inhibitors used in conventional ED care; oxytocin is included for its role in pairing and arousal rather than as a third vasodilator.

Omzo also runs weight-loss, hair, and other telehealth pillars. ED treatment here sits inside a broader clinic relationship, with check-ins after the first plan rather than a one-time bottle checkout. That is useful if you want ongoing support; it is extra process if you only want a refillable ED prescription.

A roughly five-minute assessment covers goals and health history. A licensed clinician reviews the file and, if appropriate, issues a plan. The troche ships in plain packaging. Omzo describes follow-up check-ins and in-app support as part of the program.

Strength options reported by third-party roundups include a medium (sildenafil 20mg / tadalafil 5mg) and a high (100mg / 20mg) troche. Confirm the actual prescription on your label. Do not combine this with other PDE5 inhibitors or nitrates.

Omzo does not always publish a hard ED price on the marketing page; the figure often appears after the quiz. Independent roundups have placed plans around $130–$249 per month depending on strength and supply. Treat those numbers as directional until checkout.

Free or expedited delivery is part of the brand's standard pitch. Because pricing is less transparent up front than BetterMe Rx or MEDVi, it is worth screenshotting the quoted total before you submit payment.

Omzo is best for men who want a discreet, fully online sexual-health plan and are specifically interested in a troche that adds oxytocin rather than a third PDE5 inhibitor or apomorphine. The privacy and check-in model is the other differentiator.

It is a poorer match if you need a published price before starting, want a 4-in-1 drop instead of a 3-in-1 troche, or are looking for FDA-evaluated single-ingredient generics only. Compounded combinations are not a substitute for an in-person workup when cardiovascular risk is high.